Quit Smoking
Professor’s Efforts To Help Smokers Quit
US academy honours professor for efforts to help smokers quit
Colleen Lee – Updated on Nov 10, 2008 – SCMP
Sophia Chan Siu-chee noticed in the early 1990s that while doctors were advising patients to quit smoking, there were no medical workers helping them to do so.
So she decided to train nurses to help smokers kick the habit – and yesterday, her efforts won her international recognition.
Professor Chan, head of the University of Hong Kong’s Department of Nursing Studies, became the first Hongkonger to be named an international fellow of the American Academy of Nursing.
“I feel very honoured and happy,” said Professor Chan, one of three international fellows chosen this year.
She said that in the early 1990s, no medical staff were dedicated to helping smokers quit.
“When a doctor saw a patient smoking, he might just advise him not to smoke. And that was it … no one would do any follow-up.”
From 1993 to 1999, she studied part-time for her doctorate in public health at the University of Hong Kong, devoting herself to studying the use of counselling to stop smoking. Once she graduated, she decided to help promote that idea in the community.
She said that since 2000, she had helped the Hospital Authority train about 200 nurses in such skills. These nurses later played a key role in the authority’s Smoking Counselling and Cessation Centres, founded in 2002. The centres now number 16.
Professor Chan said she hoped her fellowship would encourage nurses in Hong Kong, adding that their morale had recently been affected by a staff shortage.
“Many nurses here work very hard … I hope more and more local nurses will be awarded fellowships by the academy,” she said.
Professor Chan said she next planned to study women’s smoking rates globally to find out the possible reasons for differences in various places. She said, for example, that Hong Kong and Japan were both metropolitan, but smoking was less prevalent among local women than those in Japan.
Professor Chan and the other two international fellows named this year were inducted along with 89 Americans as fellows at a ceremony in Scottsdale, Arizona.
The academy, set up in 1973, aims to anticipate American and international trends in health care and to address relevant issues.
The fellowship recognises individuals’ contributions to nursing and health care.
Mobile Smoking Cessation Programme
Effectiveness Of A Mobile Smoking Cessation Service In Reaching Elderly Smokers And Predictors Of Quitting: Report
Author: Abu Saleh M Abdullah, Tai-Hing Lam, Steve KK Chan, Gabriel M Leung, Iris Chi, Winnie WN Ho and Sophia SC Chan
Credits/Source: BMC Geriatrics 2008, 8:25
Different smoking cessation programmes have been developed in the last decade but utilization by the elderly is low. We evaluated a pilot mobile smoking cessation service for the Chinese elderly in Hong Kong and identified predictors of quitting.
Methods: The Mobile Smoking Cessation Programme (MSCP) targeted elderly smokers (aged 60 or above) and provided service in a place that was convenient to the elderly. Trained counsellors provided individual counselling and 4 week’s free supply of nicotine replacement therapy (NRT).
Follow up was arranged at 1 month by face-to-face and at 3 and 6 months by telephone plus urinary cotinine validation. A structured record sheet was used for data collection.
The service was evaluated in terms of process, outcome and cost.
Results: 102 governmental and non-governmental social service units and private residential homes for the elderly participated in the MSCP. We held 90 health talks with 3266 elderly (1140 smokers and 2126 non-smokers) attended.
Of the 1140 smokers, 365 (32%) received intensive smoking cessation service. By intention-to-treat, the validated 7 day point prevalence quit rate was 20.3% (95% confidence interval: 16.2%-24.8%).
Smoking less than 11 cigarettes per day and being adherent to NRT for 4 weeks or more were significant predictors of quitting. The average cost per contact was US$54 (smokers only); per smoker with counselling: US$168; per self-reported quitter: US$594; and per cotinine validated quitter: US$827.
Conclusion: This mobile smoking cessation programme was acceptable to elderly Chinese smokers, with quit rate comparable to other comprehensive programmes in the West. A mobile clinic is a promising model to reach the elderly and probably other hard to reach smokers.
Smokers Increasingly Hooked On Nicotine: Study
The National Post – Will Dunham | October 29, 2008
Smokers who are seeking medical treatment to give up cigarettes are more highly addicted to nicotine than smokers who sought help two decades ago, U.S. researchers said on Tuesday.
The researchers examined nicotine dependence levels of about 600 smokers who entered treatment programs in northern California to quit smoking during three periods starting in 1989 and ending in 2006.
Seventy-three percent of those seeking medical help to quit smoking in 2005 to 2006 were deemed highly nicotine dependent using scores from a questionnaire given to assess the severity of nicotine addiction, the researchers said.
That compares to 55 percent of those seeking such help from 1989 to 1990 and 66 percent of those seeking treatment in 1994, Dr. David Sachs of the Palo Alto Center for Pulmonary Disease Prevention in California told a meeting of the American College of Chest Physicians.
Sachs said the findings suggest nicotine dependence is worsening among U.S. smokers as a whole, although researchers don’t know why.
A report published by the Massachusetts Department of Public Health in 2006 found that levels of nicotine in most cigarettes rose by nearly 10 percent from 1998 to 2004.
Medical treatment to help people quit smoking may include nicotine replacement therapy such as a patch that delivers nicotine through the skin and into the bloodstream, nicotine gums, nasal sprays and inhalers, and antidepressant medication that raises the level of a brain chemical called dopamine.
The new study’s findings are “important because what studies have consistently shown is that the more physically dependent a cigarette smoker is, the more intensive the treatment needs to be if the patient is going to be able to have a good treatment outcome and be able to stop smoking,” Sachs said in a telephone interview.
“If you look at all of the cigarette smokers that we have around the United States, roughly three-fourths of them are going to be highly physically nicotine dependent,” Sachs said.
An estimated 21 percent of U.S. adults — 45 million people — are smokers, including 24 percent of men and 18 percent of women, according to the U.S. Centers for Disease Control and Prevention.
The questionnaire, used to determine the degree of a person’s of nicotine dependence, asked a smoker a number of questions such as whether they smoke their first cigarette within 30 minutes of waking up in the morning.
Other questions include whether they find it difficult to refrain from smoking in places where it is forbidden, how many cigarettes they smoke daily and whether they smoke even when they are so ill that they are bed-ridden.
See conference website:
CHEST 2008
http://www.chestnet.org/…
Effective Anti-tobacco Ads Should Either Scare Or Disgust Viewers
ScienceDaily | Oct. 22, 2008
Anti-tobacco public service announcements have been around for decades, designed to encourage people to quit smoking or to refrain from starting. Often these ads try to encourage people to avoid smoking by scaring them with the harmful effects of tobacco use.
In a new study, University of Missouri researchers examined the effects of two types of content commonly used in anti-tobacco ads – tobacco health threats that evoke fear and disturbing or disgusting images. The researchers found that ads focused on either fear or disgust increased attention and memory in viewers; however, ads that included both fear and disgust decreased viewers’ attention and memory.
“When fear and disgust are combined in a single television ad, the ad might become too noxious for the viewer,” said Glenn Leshner, lead author of the study and co-director of the Psychological Research on Information and Media Effects (PRIME) Lab in the Missouri School of Journalism. “We noticed several ads in our collection of anti-tobacco public service announcements that contained very disturbing images, such as cholesterol being squeezed from a human artery, a diseased lung, or a cancer-riddled tongue. Presumably, these messages are designed to scare people so that they don’t smoke. It appears that this strategy may backfire.”
There is limited understanding of the cognitive and emotional processes associated with the effects of advertising messages, according to Paul Bolls, co-author of the study and co-director of the PRIME Lab. Bolls said the purpose of the study was to examine key characteristics of anti-tobacco ads that influence viewers’ cognitive processes engaged during message exposure, which potentially contribute to the messages’ effectiveness.
“This study provides important insight into how young adults process anti-smoking messages, and it offers practical suggestions for designing effective tobacco prevention messages,” Bolls said. “The way the human mind perceives and processes information in a persuasive message is the very foundation of any desired effect on targeted individuals. The PRIME lab at MU is dedicated to studying how very specific elements of health campaign messages engage attention and emotion so that messages can be produced that might actually help persuade individuals to adopt healthier attitudes and behaviors.”
The researchers measured the physiological responses of 58 viewers while the viewers watched a series of 30-second anti-tobacco ads. The ads included fear messages that communicated health threats resulting from tobacco use (lung cancer, heart disease, etc.) or disgust content that focused on negative graphic images (dirty insects, blood, organs, etc.) or both fear and disgust content.
Electrodes were placed on the viewers’ facial muscles to measure emotional responses. Attention, which was defined as the amount of mental effort participants expended to interpret the messages, was measured by taking participants’ heart rates. To measure recognition, the participants completed a visual recognition task that consisted of watching brief video scenes (1 second) while pressing computer keys to indicate whether or not they believed the scene was from one of the ads they viewed during the experiment.
Journal reference:
1. Scare Them or Disgust Them: the effect of graphic health promotion messages. Health Communication, (in press)
Adapted from materials provided by University of Missouri-Columbia.
Obesity, Smoking All Time Bombs
Reuters in Hong Kong | Oct 20, 2008
Chronic illnesses such as cancer and heart and respiratory diseases are ticking time bombs in the mainland, and Chinese must cut their intake of fatty foods and salt, stop smoking and start exercising, health experts said.
Increasingly affluent mainlanders in urban and rural areas consumed between 25 and 100 per cent more fat each day in 2002 compared with 1982, sharply raising the risk of heart disease and cancer, the experts wrote in The Lancet medical journal.
The report, by researchers in China and the United States, is part of a special series on the country’s health reforms.
While the country was plagued by infectious diseases before 1990, chronic illnesses are now its main health problem and they accounted for 74.1 per cent of all deaths in 2005, up from 47.1 per cent in 1973, the researchers wrote.
While these chronic illnesses have to do with people living longer, several high-risk factors are also involved.
Apart from a fatty diet, many mainlanders consume a relatively high 12-gram dosage of salt daily, which the paper said accounted for hypertension in some 177 million adults.
Based on mainland definitions, 22.8 per cent of Chinese were overweight in 2002, up 39 per cent from 1992. Some 7.1 per cent in the population were obese in 2002.
The paper also drew attention to the country’s smoking habit.
“One in every three smokers in the world is a Chinese man… consumption of cigarettes increased to 2,022 billion in 2006, 17.4 per cent higher than in 2002,” they wrote.
The average mainland male smoker smoked 15 cigarettes a day in 2002, up from 13 in 1984.
The costs of the mainland’s disease burden from smoking were likely to be vast, and China will suffer reduced productivity and more premature deaths, the researchers warned.
“Hypertension and tobacco can be targeted health priorities. Reduction of salt intake should become a national campaign,” wrote the team, led by Yang Gonghuan of the Chinese Centre for Disease Control and Prevention in Beijing.
In another paper, also in the Lancet series, a team led by Yuanli Liu of the Harvard School of Public Health said only 12 per cent of hypertension patients in urban areas and seven per cent in the countryside were covered by treatment.
While 45 and 50 per cent of men in urban and rural areas were regular smokers in 2003, only 5-6 per cent of them tried to quit.
In an accompanying comment, Xiao Shuiyuan of China’s Central South University and Matthew Korman of Stanford University in the United States warned of dire consequences.
“If present smoking trends continue, 100 million Chinese men will die (of smoking-related causes) between 2000 and 2050, with many of their family members squandering life savings in desperate attempts at treatment,” the two scientists wrote.
Addicted To Nicotine Gum
JANE SYMONS – The Sun Newspaper | 17 Oct 2008
RUBY WAX gave up smoking 12 years ago but remained hooked on nicotine for another ten years.
The nicotine replacement gum that should have been the solution to her addiction became a bigger problem than cigarettes ever were.
Ruby admits: “I was really addicted. I used the chewing gum for about ten years.
“I was chewing it even though I had sores in my mouth and it was doing terrible things to my stomach.”
Ruby ignored the instructions to chew the gum a couple of times then leave it in the mouth to slowly release nicotine.
Instead, she chomped through piece after piece, demolishing two packs of gum a day -the equivalent of 48 cigarettes.
Health experts recommend using no more than 15 pieces of nicotine replacement gum a day and advise quitters to try to wean themselves off it within three months.
But Ruby, who is about to start filming a new sitcom in Kenya, ignored the warnings and developed the secrecy and sneakiness that often go hand in hand with an addiction.
She admits: “I would buy it from different chemists so they didn’t realise how much I was using. It was so hard. If I had one, I would eat the whole pack.
“It cost me just as much as cigarettes and it was just as dangerous -you still get cancer, just a different type of cancer.”
Ruby found it easy to keep her nicotine addiction secret.
There was no telltale smell of stale smoke and the constant chewing became part of her sassy American image.
Not even her own children realised she was hooked. Ruby finally conquered her gum habit with the help of counsellors from Allen Carr’s Easyway.
But she says: “It still lurks around the corner. If I’m in a pharmacy I’ll notice the gum, like an old lover.”
The HK Broadcasting Authority’s Public Consultation on Provisions on Advertising of Nicotine Replacement Therapy Products (WC2/2008)
Dr Judith Mackay – World Lung Foundation/Bloomberg Initiative – Asian Consultancy on Tobacco Control – 17 October 2008
Background
The harm caused by smoking is immediately reduced and can be virtually eliminated over time after smokers quit. This is true even for lifelong smokers.
Many people have little trouble kicking the habit, while others struggle through a difficult cycle of personal change.
While most smokers quit on their own (“cold turkey”), there are an increasing number of programmes and aides are helping to liberate smokers from their addiction. Nicotine replacement therapies (gum, patch, and inhaler) are available, with or without prescription, in most countries. Pharmacologic agents, such as bupropion and varenicline, are widely approved for use in smoking cessation.
Cessation programs not only change individual lives, they also reshape social norms and community values, fostering a world where children are less likely to casually experiment with cigarettes, and the confidence of adults in their ability to quit is strengthened.
NRT
NRT is a product entirely designed and marketed to encourage smokers to quit. NRT is pure nicotine. It is nicotine for which smokers smoke, so NRT satisfies smokers’ craving for smoking, yet delivers a much safer product. NRT therefore does not contain any of the cancer-producing elements, or thothat cause chronic obstructive pulmonary disease. Nicotine has an effect on the arteries, but this single component is infinitely safer than the thousands of dangerous chemicals in tobacco.
NRT doubles, if not trebles the quitting rates, if used properly, with support. It behoves the health authorities to support and promote the use of any product that saves lives to this extent.
There is no evidence that NRT encourages youth non-smokers to start smoking
In practice, the pharmaceutical industry puts funds into promoting NRT, and this amplifies any health promotion that the health departments and organisations are producing.
I do not know of any circumstances where the marketing of NRT has been in conflict with the messages of the health authorities.
HK Consultation document
Section 5 a, b:
I am not convinced that the advertisements for NRT need to comply with the advertisements for tobacco itself. The latter is in a uniquely different category, killing 50% of its users. NRT is designed to save lives.
Clauses 5 c,d,e are sensible and acceptable.
In addition to the relaxing of the advertising of NRT, the issue of allowing broadcasting of other proven tobacco cessation products cannot be ignored, and should be considered. I am not proposing a free for all, but only those approved by a medical licensing authority, or approved by WHO.
Finally, World Health Organisation is fully in favour of Public-Private partnerships, such as with the pharmaceutical industry, as it is realised that tobacco use cannot be reduced by the public sector alone.
Dr Judith Mackay, SBS, OBE, FRCP(Edin), FRCP(Lon)
Director, Asian Consultancy on Tobacco Control
Riftswood, 9th milestone
DD 229, Lot 147
Clearwater Bay Road
Kowloon, Hong Kong
Tel: +852 2719-1995
Fax: +852 2719-5741
Email: jmackay@pacific.net.hk
Success Of Nicotine Replacement Therapy Unproven
13 Oct 2008
As smokers spend millions of dollars purchasing over-the-counter nicotine replacement therapy, a Hunter researcher has revealed the treatments are of uncertain effectiveness when used alone.
Associate Professor Raoul Walsh from the Centre for Health Research and Psycho-oncology (CHeRP) reviewed 12 studies relating to the effectiveness of over-the-counter nicotine replacement therapy. He discovered that the results of the studies did not convincingly demonstrate that the therapy, when used alone without additional support, was effective in helping smokers to quit.
Associate Professor Walsh said his review revealed that the methods used in nicotine replacement therapy trials were very different from real life. Based on the results, people cannot make valid assumptions on the effectiveness of the therapies.
“Nicotine replacement therapies, such as nicotine gum, lozenges or patches, purchased at the local supermarket can be effective as part of an overall strategy to help people stop smoking. However we do not really know the long term success of over-the-counter nicotine replacement therapy when used alone without additional support.
“Many smokers regard patches as magic bullets in their quest to stop smoking. This may be misleading because minimal support, such as medical advice or telephone counselling, in addition to the patches may be the necessary ingredients for achieving modest success rates.”
Associate Professor Walsh said it was important that over-optimistic assumptions were not made about the effectiveness of the therapy when purchased over the counter.
“To gain realistic measures of success, future research must involve more innovative, rigorous controlled trials where nicotine dependence is adequately assessed.”
Associate Professor Walsh’s review findings are published in the latest edition of the journal Drug and Alcohol Review. He hopes the review will result in education programs that emphasise the need for people to use over-the-counter nicotine replacement therapy in conjunction with other strategies.
(Source: Drug and Alcohol Review: University of Newcastle: October 2008)
Study Reveals Mechanism Behind Nicotine Dependency
The Scripps Research Institute By Gary Kuhlman and Mika Ono Benedyk – October 8, 2007
Many more people try to quit smoking than succeed in giving up this nicotine-delivering habit. Now, a group of scientists at The Scripps Research Institute has identified one neurobiological mechanism that contributes to nicotine dependence, and to the anxiety and craving experienced upon withdrawal. The findings also suggest a new approach to developing drugs that could help smokers quit.
The research was published the week of October 1, 2007, in an advance, online issue of the journal Proceedings of the National Academy of Sciences(PNAS).
The new study reveals that, in rats, chronic nicotine use recruits a major brain stress system, the extrahypothalamic corticotropin releasing factor (CRF) system, which contributes to continued tobacco use by exacerbating anxiety and craving upon withdrawal. The researchers found that administering a compound that blocked the receptors involved in this stress system alleviated withdrawal symptoms.
“We reduced the need to take nicotine by blocking CRF-1 receptors in the brain,” says Olivier George, a research associate in the Scripps Research Koob lab who conducted the study with Sandy Ghozland and other colleagues. “We were surprised by the compound’s dramatic effectiveness. We don’t know yet if the same mechanism is involved in humans with tobacco dependence, but it is very promising.”
Tobacco addiction is the leading avoidable cause of disease and premature death in the United States, responsible for more than 438,000 deaths annually, according to the Centers for Disease Control and Prevention. Nicotine, the main psychoactive ingredient in tobacco, is a tough drug, with smokers continuing to crave it long after they’ve started withdrawal. Most smoking-cessation medication is based on nicotine replacement therapy, using nicotine gum or patches, that substitutes one source of nicotine for another. Roughly 80 percent of smokers who try to quit relapse within a year.
While nicotine can produce mildly pleasurable effects, the Scripps Research scientists believe a more important factor in the difficulty in quitting is the brain’s adaptation to that reward, which produces an intense discomfort upon withdrawal.
“The key in nicotine addiction is that the positive pleasurable effects of nicotine are instantaneous and short lasting, while the negative effects are delayed and long lasting,” George says. “Even if nicotine may transiently induce a relief from a negative emotional state, its long-term consequences are disastrous.”
For years, scientists have wanted to know what changes in the brain occur in the transition from nicotine use to nicotine dependence. In the current study, the researchers set out to see if nicotine dependence is linked to changes in the CRF system in the amygdala, an area of the brain that plays a primary role in the processing and memory of emotional reactions. The CRF system is activated by CRF-1, an essential protein for coping with stressful events.
When the researchers induced nicotine withdrawal in rats, the nicotine-deprived group exhibited severe anxiety-like behavioral symptoms of withdrawal—such as burying and “freezing” (becoming motionless)—compared with controls. In addition, withdrawal whetted the rats’ appetite for even greater quantities of the drug, a result the researchers call the “nicotine deprivation effect.”
“Rats exhibited drug-loading behavior following a cycle of abstinence, attaining an amount of nicotine in roughly six hours that previously took 12 hours,” George says. “This is like the light smoker becoming a chain smoker after trying to quit.”
Measurements showed this behavior was indeed matched by hyperactivity in the CRF system, and that these withdrawal effects lasted a surprisingly long time. In addicted rats, these effects developed in under a week and maintained a hold for at least two months.
“That’s a long time for a rat, considering its life expectancy is two years,” says George. “These results suggest long-lasting neuroadaptations of the CRF system, possibly through gene regulation, that may help explain why many cigarette smokers relapse even after a long abstinence from smoking.”
Importantly, the researchers were able to moderate the effects of nicotine deprivation. When addicted rats were injected with a CRF receptor antagonist, the injected rats showed less anxiety-like behavior during withdrawal and self-administered less nicotine compared with an addicted controls.
The Scripps Research scientists hope their work will lead to new nicotine-free pharmacological treatments, as well as shedding light on questions such as what makes some people more likely than others to become addicted in the first place.
In addition to George and Ghozland, authors of the paper, titled “CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine dependent rats,” are Marc R. Azar, Pietro Cottone, Eric P. Zorrilla, Loren H. Parsons, Heather N. Richardson, and George F. Koob of The Scripps Research Institute; and Laura E. O’Dell of the University of Texas, El Paso.
The research was supported by the Tobacco Related Disease Research Program of the State of California, the National Institutes of Health, the Pearson Center for Alcoholism and Addiction Research at The Scripps Research Institute, and the Tobacco Etiology Research Network of the Robert Wood Johnson Foundation.
Send comments to: mikaono@scripps.edu